9900 Westpoint Dr, Suite 128
Indianapolis, IN 46256
Twitter: @GenezenLabs https://twitter.com/GenezenLabs
Founded in Indianapolis in 2014, Genezen Laboratories is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP vector production, and analytical testing services, building on the company’s expansive knowledge and experience in the industry and working with the nation’s leading institutions.
Genezen recently began construction on a 25,000 square foot initial phase of a larger cGMP-compliant lentiviral vector production facility in the Midwest which will include multiple cGMP production with capabilities for host cell expansion, host cell banking, and viral vector production via transient transfection and producer cell lines. The vector product will be aseptically filled into sterile bags providing the ideal presentation for use in cell therapy.
GMP Vector Production
Click here to view/download Genezen’s latest poster: Development of a Transfection-Based, Scalable, Serum-Free, Single-Use Suspension Platform for Manufacturing Lentiviral Vector
Posted Date: 6/16/2021
This record has been viewed 2660 times.